TRACEY HYLTON: Open Payments
NPI 1679173785 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 118 payments from 25 companies in 2025. Trend: 2023 $15 · 2024 $617 · 2025 $2,694
Food & beverage: $2,619Education: $76
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $552 |
| ABBVIE INC. | 21 | $418 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $242 |
| Alkermes, Inc. | 14 | $230 |
| Axsome Therapeutics, Inc. | 8 | $228 |
| Braeburn Inc. | 6 | $197 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
| Vanda Pharmaceuticals Inc. | 7 | $140 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
Products named: VRAYLAR, AUSTEDO XR, CAPLYTA, Auvelity, BRIXADI, UZEDY, ARISTADA, FANAPT.
Industry payments across OH — which companies pay providers there.
